{
    "clinical_study": {
        "@rank": "15113", 
        "arm_group": {
            "arm_group_label": "Regadenoson", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to measure the changes in cardiac function during a Lexiscan\n      pharmacologic stress test using cardiac magnetic resonance imaging test."
        }, 
        "brief_title": "Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Myocardial rest/regadenoson stress perfusion PET study within 60 days\n\n          -  Normal rest LVEF (greater than or equal to 50%)\n\n          -  No change in symptoms or treatment between the PET and the MRI study\n\n          -  Willing to consent to the study\n\n          -  Male or female who is either post-menopausal, surgically sterile, or if has a\n             childbearing potential, a negative pregnancy test within 2 days prior to the MRI\n             study.\n\n        Exclusion Criteria:\n\n          -  Renal dysfunction (estimated glomerular filtration rate < 60 mL/min/1.73m2) within 6\n             months\n\n          -  Metallic implants, pacemaker, blood vessel clip (contra-indicated for MRI)\n\n          -  Patient size exceeds MRI bore/table limits: (Max body diameter > 60 cm, weight > 136\n             kg)\n\n          -  History of gadolinium contrast allergy or intolerance\n\n          -  Second or third degree AV block\n\n          -  Sinus node dysfunction\n\n          -  Acute myocardial infarction (past 3 months)\n\n          -  Actively wheezing or with acute asthma or bronchospastic attacks requiring changes in\n             therapy within the past 30 days\n\n          -  Patients that have experienced a previous hypersensitivity reaction thought to be\n             related to regadenoson"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "90 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02115308", 
            "org_study_id": "Astellas CMR Tagging"
        }, 
        "intervention": {
            "arm_group_label": "Regadenoson", 
            "intervention_name": "Regadenoson", 
            "intervention_type": "Drug", 
            "other_name": "Lexiscan"
        }, 
        "intervention_browse": {
            "mesh_term": "Regadenoson"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 14, 2014", 
        "location": {
            "contact": {
                "email": "scourter@cvit.com", 
                "last_name": "Staci A Courter, MA", 
                "phone": "816-531-2842", 
                "phone_ext": "10"
            }, 
            "facility": {
                "address": {
                    "city": "Kansas City", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "64111"
                }, 
                "name": "Saint Luke's Health System"
            }, 
            "investigator": [
                {
                    "last_name": "Joseph Soltys, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "James A Case, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ibrahim Saeed, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Timothy M Bateman, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging", 
        "overall_contact": {
            "email": "scourter@cvit.com", 
            "last_name": "Staci A Courter, MA", 
            "phone": "816-531-2842", 
            "phone_ext": "107"
        }, 
        "overall_official": {
            "affiliation": "Aspire Foundation", 
            "last_name": "Timothy M Bateman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Strain (\u0394R) and/or displacement (\u0394\u03b8) of normal and abnormal segments", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Strain (\u0394R) and/or displacement (\u0394\u03b8) between segment classifications (normal, reversible, and non-reversible perfusion defects)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02115308"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Aspire Foundation", 
            "investigator_full_name": "Timothy M. Bateman", 
            "investigator_title": "Medical Director", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Strain (\u0394R) and/or displacement (\u0394\u03b8) score correlation with flow reserve as measured by PET and/or transmural extent of infarction (TEI) indicated by Late Gadolinium Enhancement (LGE)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1"
            }
        ], 
        "source": "Aspire Foundation", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Saint Luke's Health System", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Saint Luke's Cardiovascular Consultants", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Timothy M. Bateman", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}